Pentaveri-IV Injection
Marketer
Neoveritas Healthcare Pvt. Ltd
Salt Composition
Pantoprazole (40mg)
Overview Pentaveri-IV Injection
AcidGard-IV is an intravenous medication that suppresses gastric acid production. It's indicated for treating stomach and intestinal conditions stemming from excess acid, including acid reflux, peptic ulcers, and Zollinger-Ellison syndrome. It offers symptomatic relief and facilitates healing. AcidGard-IV also prevents stress ulcers in critically ill patients and is pre-operatively administered to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), this injectable medication is administered by a healthcare professional only when deemed superior to oral forms by your physician. Dosage is individualized based on your condition and response. Treatment duration is determined by your doctor; continue as directed, even with rapid symptom resolution. Lifestyle modifications, such as frequent small meals and avoidance of caffeine, spicy foods, and fatty foods, can enhance treatment efficacy. Common side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, abdominal pain, and thrombophlebitis (vein inflammation). While generally mild, persistent or bothersome effects require medical attention. Prolonged use, especially exceeding one year, may elevate the fracture risk, particularly at higher doses. Discuss bone health strategies, such as calcium and vitamin D supplementation, with your physician. AcidGard-IV is contraindicated in individuals with severe hepatic impairment, those on HIV medications, those with a history of PPI allergy, or existing osteoporosis. Pregnant or breastfeeding individuals should consult their doctor before use. Alcohol should be avoided due to its acid-stimulating effects. Refrain from operating machinery if dizziness or drowsiness occurs.
Primary Ingredients of Pentaveri-IV Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Pentaveri-IV Injection
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Pentaveri-IV Injection:
Administering this medication will be done by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Pentaveri-IV Injection:
- Diarrhea
- Flatulence
- Headache
- Joint pain
- Nausea
- Stomach pain
- Vomiting
- Dizziness
- Thrombophlebitis
How to use Pentaveri-IV Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Pentaveri-IV Injection works:
Stomach acid is neutralized by Pentaveri-IV Injection, a proton pump inhibitor (PPI), thus alleviating symptoms of heartburn and acid indigestion.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Pentaveri-IV Injection is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Administering Pentaveri-IV Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administration of Pentaveri-IV Injection during lactation appears unlikely to pose a substantial risk. Available human data indicate minimal danger to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Pentaveri-IV Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Pentaveri-IV Injection poses no safety concerns for patients with renal impairment; no dosage modification is necessary.
LiverCAUTION
Patients with severe hepatic impairment should receive Pentaveri-IV Injection only with close monitoring. Dosage modification for Pentaveri-IV Injection may be necessary. Physician consultation is advised.
What if you forget to take Pentaveri-IV Injection :
Should you forget a Pentaveri-IV Injection dose, seek your physician's advice.
Facts to Know About Pentaveri-IV Injection
| Label | Value |
|---|---|
| Chemical Category | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Type of Therapy | Gastrointestinal system |
| Behavioral Class | Gastric acid suppressants |






